They may be more suitable for treating patients with depression accompanied by anxiety symptoms compared to existing antidepressants; rapid onset: 5-HT1A receptor ligands demonstrate rapid onset, likely due to their direct agonistic effect on 5-HT1A receptors. Here, HTR1A is linked to major depressive disorder.